Abstract
In an ideal world, no new treatments should be introduced into medicine until they have been shown to be more effective, safer or less expensive than existing treatments (Cochrane 1971). In the real world, once new treatments have been shown to be effective, they are quickly promoted by their makers. The methods of the marketplace, rather than scientific argument about effectiveness, safety and cost, are used to encourage clinicians to adopt the new treatments. Before 1936, psychiatry, like much of general medicine, had few treatments that were specifically effective. Even so, the advice of clinicians was highly prized — at best, people did well with sage advice and encouragement, and at worst, people with serious disorders could be shown how to lessen the impending tragedy, while people with disorders likely to remit could be shown how to manage until the remission occurred.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andreason NC (1982) Negative symptoms in schizophrenia. Arch Gen Psychiatry 39: 784–788
Andreason NC, Olsen S (1982) Negative versus positive schizophrenia: definition and validation. Arch Gen Psychiatry 39: 789–794
Andrews G (1993) The essential psychotherapies. Br J Psychiatry 162: 447–451
Andrews G, Harvey R (1981) Does psychotherapy benefit neurotic patients? A reanalysis of the Smith, Glass and Miller data. Arch Gen Psychiatry 38: 1203–1208
Andrews G, Craig A, Feyer A-M, Hoddinott S, Howie PM, Neilson M (1983) Stuttering: a review of research findings and theories circa 1982. J Speech Hear Disord 48: 226–246
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4: 561–571
Beck AT, Epstein N, Brown G, Steer RA (1988) An inventory for measuring clinical anxiety: psychometric properties. J Cons Clin Psychol 56: 893–897
Cochrane AL (1971) Effectiveness and efficiency. Random reflections on the health service. Nuffield Provincial Hospitals Trust, Oxford
Derogatis LR (1977) SCL-90-R: administration, scoring and procedures manual-I. Johns Hopkins University, Maryland
Eisen SV, Dill DL, Grob MC (1994) Reliability and validity of a brief patient-report instrument for psychiatric outcome evaluation. Hosp Community Psychiatry 45: 242–247
Glass GV (1976) Primary, secondary and meta-analysis of research. Educational Researcher 10: 3–8
Goldberg D (1972) The detection of psychiatric illness by questionnaire. Oxford University Press, London
Goodman SH, Sewell DR, Cooley EL, Leavitt N (1993) Assessing levels of adaptive functioning: the Role Functioning Scale. Community Ment Health J 29: 119–131
Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32: 50–55
Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Social Clin Psychol 6: 278–296
Kluiter H, Wiersma D (1996) Randomized controlled trials of programmes. In: Knudsen HC, Thornicroft G (eds) Mental health service evaluation. Cambridge University Press, Cambridge
Jablensky A, Schwartz R, Tomov T (1980) WHO collaborative study on impairments and disabilities associated with schizophrenic disorders. Acta Psychiatr Scand [Suppl] 285: 152–163
Overall J, Gorham D (1962) The Brief Psychiatric Rating Scale. Psychol Rep 10: 799–812
Quality Assurance Project (1983) A treatment outline for depressive disorders. Aust N Z J Psychiatry 17: 129–148
Sackett DL, Haynes RB, Tugwell P (1985) Clinical epidemiology. Little and Brown, Boston
Sartorius N, de Girolamo G, Andrews G, German A, Eisenberg L (eds) (1993) Treatment of mental disorders: a review of effectiveness. American Psychiatric Press, Washington
Spielberger C (1983) Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto
Treatment Protocol Project (2000) Management of mental disorders. World Health Organisation Collaborating Centre for Mental Health and Substance Abuse, Sydney, Australia
Veit CT, Ware Jr JE (1983) The structure of psychological distress and well-being in general populations. J Consult Clin Psychol 51: 730–742
Ware JE, Sherbourne CD (1992) The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 30: 473–483
Wing J (1994) Health of the Nation Outcome Scales: HoNOS Field Trials. Royal College of Psychiatrists Research Unit, London
World Health Organization (1997) CIDI-Auto 2.1 Administrator’s guide and reference. World Health Organisation Collaborating Centre for Mental Health and Substance Abuse, Darlinghurst
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Andrews, G. (2001). Evaluation of Psychiatric Treatments. In: Henn, F., Sartorius, N., Helmchen, H., Lauter, H. (eds) Contemporary Psychiatry. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59519-6_33
Download citation
DOI: https://doi.org/10.1007/978-3-642-59519-6_33
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64007-0
Online ISBN: 978-3-642-59519-6
eBook Packages: Springer Book Archive